Advanced search
Publication Cover
International Medical Case Reports Journal Volume 13, 2020 - Issue
Submit an article Journal homepage
120
Views
0
CrossRef citations to date
0
Altmetric
Case report

Resolution of Long-Standing Diabetes Mellitus Two Years After Surgery for Growth Hormone Producing Pituitary Tumor

Poorna Gopal Azad Sreeramaneni1 Department of Endocrinology, Sreeramaneni Sumanth Krishna Endocrinology, Diabetes and Thyroid Hospitals, Vijayawada, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2670-3631View further author information
ORCID Icon &
Rajesh K Ghanta2 Department of Neurosurgery, Suraksha Hospitals, Vijayawada, IndiaView further author information
Pages 71-75 | Published online: 28 Feb 2020

References

  • Page KA, Reisman T. Interventions to preserve beta-cell function in the management and prevention of type 2 diabetes. Curr Diab Rep. 2013;13(2):252–260. doi:10.1007/s11892-013-0363-2
  • Acromegaly. Available from: https://www.niddk.nih.gov/health-information/endocrine-diseases/acromegaly. Accessed January 18,2020.
  • Dineen R, Stewart PM, Sherlock M. Acromegaly. QJM Int J Med. 2017;110(7):411–420. doi:10.1093/qjmed/hcw004
  • Takano A, Haruta T, Iwata M, et al. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3t3-l1 adipocytes. Diabetes. 2001;50:1891–1900. doi:10.2337/diabetes.50.8.1891
  • Vila G, Jørgensen JO, Luger A, Stalla GK. Insulin resistance in patients with acromegaly. Frontiers in Endocrinology. 2019;10. doi:10.3389/fendo.2019.00509
  • Lavrentaki A, Paluzzi A, JA W, Karavitaki N. Epidemiology of acromegaly: review of population studies. Pituitary. 2017;20(1):4–9. doi:10.1007/s11102-016-0754-x
  • Hannon AM, Thompson CJ, Sherlock M. Diabetes in Patients With Acromegaly. Curr Diab Rep. 2017;17(2):8. doi:10.1007/s11892-017-0838-7
  • Møller N, Jørgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev. 2009;30(2):152–177. doi:10.1210/er.2008-0027
  • Smith U, Attvall S, Eriksson J, Fowelin J, Lönnroth P, Wesslau C. The insulin-antagonistic effect of the counterregulatory hormones — clinical and mechanistic aspects. In: Östenson CG, Efendić S, Vranic M, editors. New Concepts in the Pathogenesis of NIDDM. Boston, MA: Springer; 1993. doi:10.1007/978-1-4615-2910-1_12
  • Simmons LR, Hughes K, Markovic TP, Elizabeth L. Patients with acromegaly also develop ketoacidosis. Chua Clin Diabetes. 2012;30(4):170–172. doi:10.2337/diaclin.30.4.170
  • Vijayakumar A, Yakar S, LeRoith D. The intricate role of growth hormone in metabolism. Front Endocrinol. 2011;2. doi:10.3389/fendo.2011.00032.
  • Abs R, Verhelst J, Maiter D, et al. Cabergoline in the treatment of acromegaly: a study in 64 patients. J Clin Endocrinol Metab. 1998;83(2):374–378. doi:10.1210/jcem.83.2.4556
  • Carrasco CA, Gadelha M, Manavela M, et al. Aggressive tumors and difficult choices in acromegaly. Pituitary. 2014;17 Suppl 1(Suppl 1):S24–S29. doi:10.1007/s11102-013-0538-5
  • Rick JW, Jahangiri A, Flanigan PM, Aghi MK. Patients cured of acromegaly do not experience improvement of their skull deformities. Pituitary. 2017;20:292–294. doi:10.1007/s11102-016-0741-2
  • Waligórska-Stachura J, Gut P, Sawicka-Gutaj N, et al. Growth hormone–secreting macroadenoma of the pituitary gland successfully treated with the radiolabeled somatostatin analog 90Y-DOTATATE: case report. J Neurosurg. 2016;125:346–349. doi:10.3171/2015.6.JNS15363

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.